William Richard White - Nov 9, 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Financial Officer
Signature
/s/ William White
Stock symbol
AKRO
Transactions as of
Nov 9, 2023
Transactions value $
$0
Form type
4
Date filed
11/13/2023, 05:37 PM
Previous filing
Sep 25, 2023
Next filing
Dec 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Award $0 +83.4K $0.00 83.4K Nov 9, 2023 Common Stock 83.4K $14.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% of the shares subject to this option shall vest and become exercisable on November 9, 2024, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.